Search Results 151-160 of 328 for ❌올인구조대 【위너보증.com / 가입코드 9122】 레볼루션 ❌

1. Sailendra G. Naidu, M.D. - Doctors and Medical Staff - Mayo Clinic

   Education · 2003. Fellow - Vascular and InterventionalMallinckrodt Institute of Radiology · 2002. Resident - Diagnostic RadiologyMallinckrodt Institute of ...

2. Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant - Mayo Clinic

   Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunosuppressive therapy, such as dexamethasone, may ...

3. Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC) - Mayo Clinic

   Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through ...

4. Intrathecally Administered Gene Therapy APB-102 in Rapidly Progressive ALS Patients with SOD1 Mutations - Mayo Clinic

   This is a Phase 1/2 open-label, multicenter study to evaluate the safety and tolerability and to explore the efficacy of gene therapy AMT-162 in Participants ...

5. A Study of Benralizumab in Patients With Eosinophilic Esophagitis - Mayo Clinic

   The purpose of this study is to compare the effect of benralizumab 30 mg every 4 weeks (Q4W) with placebo on histologic signs and gastrointestinal symptoms in ...

6. Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). - Mayo Clinic

   About this study. The purpose of this randomized, open-label, multi-center, global, Phase III study is to determine the efficacy and safety of durvalumab + ...

8. Evaluating the Effectiveness of Apremilast in the Treatment of Subjects with Canker Sores - Mayo Clinic

   The purpose of this study is to determine whether Apremalast is an effective treatment for patients with recurring canker sores. Participation eligibility.

9. S1211, Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma - Mayo Clinic

   Also, bortezomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as elotuzumab, can block ...

10. A Study of Nulojix® (Belatacept) as Maintenance Immunosuppression in Kidney Transplant Recipients - Mayo Clinic

    The primary purpose of this study is to assess the benefits and risks of changing from Cyclosporine or Tacrolimus to Belatacept between 6-60 months after kidney ...